- Home
- WSBC vs OGN Comparison
WSBC vs OGN Comparison
Compare WSBC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBC
- OGN
- Stock Information
- Founded
- WSBC 1870
- OGN 1923
- Country
- WSBC United States
- OGN United States
- Employees
- WSBC N/A
- OGN N/A
- Industry
- WSBC Major Banks
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- WSBC Finance
- OGN Health Care
- Exchange
- WSBC Nasdaq
- OGN Nasdaq
- Market Cap
- WSBC 2.8B
- OGN 2.7B
- IPO Year
- WSBC N/A
- OGN N/A
- Fundamental
- Price
- WSBC $31.35
- OGN $10.40
- Analyst Decision
- WSBC Buy
- OGN Hold
- Analyst Count
- WSBC 6
- OGN 4
- Target Price
- WSBC $38.50
- OGN $18.00
- AVG Volume (30 Days)
- WSBC 388.7K
- OGN 3.6M
- Earning Date
- WSBC 10-22-2025
- OGN 10-30-2025
- Dividend Yield
- WSBC 4.68%
- OGN 0.77%
- EPS Growth
- WSBC N/A
- OGN N/A
- EPS
- WSBC 1.65
- OGN 2.69
- Revenue
- WSBC $690,805,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- WSBC $42.49
- OGN N/A
- Revenue Next Year
- WSBC $16.47
- OGN $1.36
- P/E Ratio
- WSBC $19.21
- OGN $3.85
- Revenue Growth
- WSBC 22.64
- OGN N/A
- 52 Week Low
- WSBC $26.42
- OGN $8.01
- 52 Week High
- WSBC $37.36
- OGN $21.06
- Technical
- Relative Strength Index (RSI)
- WSBC 44.74
- OGN 60.88
- Support Level
- WSBC $31.50
- OGN $10.13
- Resistance Level
- WSBC $33.05
- OGN $10.72
- Average True Range (ATR)
- WSBC 0.57
- OGN 0.36
- MACD
- WSBC -0.13
- OGN 0.12
- Stochastic Oscillator
- WSBC 3.58
- OGN 81.87
About WSBC WesBanco Inc.
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.